Alnylam Pharma (0HD2) Cash flow

4 Followers

Alnylam Pharma Cash Flow

GB:0HD2's free cash flow for Q4 2025 was $140.26M. For the 2025 fiscal year, GB:0HD2's free cash flow was decreased by $507.97M and operating cash flow was $163.56M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 524.08M	$ -8.31M	$ 104.16M	$ -541.27M	$ -641.69M
Investing Cash Flow	$ 436.33M	$ -116.84M	$ -336.35M	$ 169.35M	$ -273.30M
Financing Cash Flow	$ -305.19M	$ 294.16M	$ 172.13M	$ 425.75M	$ 1.25B
End Cash Position	$ 1.66B	$ 968.65M	$ 814.88M	$ 868.56M	$ 822.15M
Free Cash Flow	$ 465.38M	$ -42.59M	$ 41.95M	$ -613.33M	$ -718.07M

Currency in USD